These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37883184)

  • 1. Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT.
    Drawz PE; Lenoir KM; Rai NK; Rastogi A; Chu CD; Rahbari-Oskoui FF; Whelton PK; Thomas G; McWilliams A; Agarwal AK; Suarez MM; Dobre M; Powell J; Rocco MV; Lash JP; Oparil S; Raj DS; Dwyer JP; Rahman M; Soman S; Townsend RR; Pemu P; Horwitz E; Ix JH; Tuot DS; Ishani A; Pajewski NM
    Clin J Am Soc Nephrol; 2024 Feb; 19(2):213-223. PubMed ID: 37883184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria:
    Chang AR; Kramer H; Wei G; Boucher R; Grams ME; Berlowitz D; Bhatt U; Cohen DL; Drawz P; Punzi H; Freedman BI; Haley W; Hawfield A; Horwitz E; McLouth C; Morisky D; Papademetriou V; Rocco MV; Wall B; Weiner DE; Zias A; Beddhu S;
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1121-1128. PubMed ID: 32669306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy: A Post Hoc Analysis of the SPRINT and ACCORD-BP Randomized Controlled Trials.
    Collard D; Brouwer TF; Olde Engberink RHG; Zwinderman AH; Vogt L; van den Born BH
    Hypertension; 2020 May; 75(5):1205-1212. PubMed ID: 32223381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.
    Peralta CA; McClure LA; Scherzer R; Odden MC; White CL; Shlipak M; Benavente O; Pergola P
    Circulation; 2016 Feb; 133(6):584-91. PubMed ID: 26762524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
    Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
    Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
    Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial.
    Obi Y; Kalantar-Zadeh K; Shintani A; Kovesdy CP; Hamano T
    J Intern Med; 2018 Mar; 283(3):314-327. PubMed ID: 29044764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BP Reduction, Kidney Function Decline, and Cardiovascular Events in Patients without CKD.
    Magriço R; Bigotte Vieira M; Viegas Dias C; Leitão L; Neves JS
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):73-80. PubMed ID: 29101186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Rocco MV; Sink KM; Lovato LC; Wolfgram DF; Wiegmann TB; Wall BM; Umanath K; Rahbari-Oskoui F; Porter AC; Pisoni R; Lewis CE; Lewis JB; Lash JP; Katz LA; Hawfield AT; Haley WE; Freedman BI; Dwyer JP; Drawz PE; Dobre M; Cheung AK; Campbell RC; Bhatt U; Beddhu S; Kimmel PL; Reboussin DM; Chertow GM;
    Am J Kidney Dis; 2018 Mar; 71(3):352-361. PubMed ID: 29162340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
    Kurella Tamura M; Gaussoin S; Pajewski NM; Zaharchuk G; Freedman BI; Rapp SR; Auchus AP; Haley WE; Oparil S; Kendrick J; Roumie CL; Beddhu S; Cheung AK; Williamson JD; Detre JA; Dolui S; Bryan RN; Nasrallah IM;
    Am J Kidney Dis; 2022 May; 79(5):677-687.e1. PubMed ID: 34543687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
    Beddhu S; Shen J; Cheung AK; Kimmel PL; Chertow GM; Wei G; Boucher RE; Chonchol M; Arman F; Campbell RC; Contreras G; Dwyer JP; Freedman BI; Ix JH; Kirchner K; Papademetriou V; Pisoni R; Rocco MV; Whelton PK; Greene T
    J Am Soc Nephrol; 2019 Aug; 30(8):1523-1533. PubMed ID: 31324734
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Benavente OR; Peralta CA
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1040-1047. PubMed ID: 28446537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
    Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
    Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.
    Beddhu S; Greene T; Boucher R; Cushman WC; Wei G; Stoddard G; Ix JH; Chonchol M; Kramer H; Cheung AK; Kimmel PL; Whelton PK; Chertow GM
    Lancet Diabetes Endocrinol; 2018 Jul; 6(7):555-563. PubMed ID: 29685860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Intensive BP Control in CKD.
    Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J;
    J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Intensive versus Standard BP Control on AKI and Subsequent Cardiovascular Outcomes and Mortality: Findings from the SPRINT EHR Study.
    Drawz PE; Rai NK; Lenoir KM; Suarez M; Powell JR; Raj DS; Beddhu S; Agarwal AK; Soman S; Whelton PK; Lash J; Rahbari-Oskoui FF; Dobre M; Parkulo MA; Rocco MV; McWilliams A; Dwyer JP; Thomas G; Rahman M; Oparil S; Horwitz E; Pajewski NM; Ishani A
    Kidney360; 2022 Jul; 3(7):1253-1262. PubMed ID: 35919535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
    Beddhu S; Rocco MV; Toto R; Craven TE; Greene T; Bhatt U; Cheung AK; Cohen D; Freedman BI; Hawfield AT; Killeen AA; Kimmel PL; Lash J; Papademetriou V; Rahman M; Rastogi A; Servilla K; Townsend RR; Wall B; Whelton PK;
    Ann Intern Med; 2017 Sep; 167(6):375-383. PubMed ID: 28869987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.